Imatinib Completed Phase 3 Trials for Leukemias / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Hematologic Diseases / Philadelphia Chromosome / Bone Marrow Diseases / Myeloid Leukemias Treatment

CompletedTreatment3 IdentifierTitleDrugs
NCT00002514Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
NCT00006343STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
NCT00055874Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
NCT02272777A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
NCT01511289Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients